BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23556516)

  • 1. Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease.
    Magri F; Capelli V; Gaiti M; Brambilla E; Montesion L; Rotondi M; Spinillo A; Nappi RE; Chiovato L
    Thyroid; 2013 Oct; 23(10):1312-8. PubMed ID: 23556516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
    Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L
    Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro fertilization outcomes in treated hypothyroidism.
    Busnelli A; Somigliana E; Benaglia L; Leonardi M; Ragni G; Fedele L
    Thyroid; 2013 Oct; 23(10):1319-25. PubMed ID: 23544891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid function modifications in women undergoing controlled ovarian hyperstimulation for in vitro fertilization: a systematic review and meta-analysis.
    Busnelli A; Cirillo F; Levi-Setti PE
    Fertil Steril; 2021 Jul; 116(1):218-231. PubMed ID: 33838869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.
    Witz CA; Daftary GS; Doody KJ; Park JK; Seifu Y; Yankov VI; Heiser PW;
    Fertil Steril; 2020 Aug; 114(2):321-330. PubMed ID: 32416978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
    Ye H; Huang G; Pei L; Zeng P; Luo X
    Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal thyroid function in women undergoing controlled ovarian hyperstimulation during in-vitro fertilization and its relation to reproductive outcome.
    Abdul Karim AK; Azrai Abu M; Chelliah B; Mohd Razi ZR; Omar MH; Othman H; Man ZC
    Minerva Ginecol; 2017 Oct; 69(5):431-437. PubMed ID: 28447444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE LONG-TERM IMPACT OF CONTROLLED OVARIAN HYPERSTIMULATION ON THYROID FUNCTION.
    Busnelli A; Somigliana E; Ferrari S; Filippi F; Vannucchi G; Fugazzola L; Fedele L
    Endocr Pract; 2016 Apr; 22(4):389-95. PubMed ID: 26574787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LH supplementation in mild stimulations cycles without pituitary suppression: a retrospective analysis.
    Paragona M; Rossini M; Dattilo M; Stamm J
    Gynecol Endocrinol; 2013 Feb; 29(2):101-4. PubMed ID: 23256611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid axis dysregulation during in vitro fertilization in hypothyroid-treated patients.
    Busnelli A; Somigliana E; Benaglia L; Sarais V; Ragni G; Fedele L
    Thyroid; 2014 Nov; 24(11):1650-5. PubMed ID: 25089619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis.
    Hill MJ; Levens ED; Levy G; Ryan ME; Csokmay JM; DeCherney AH; Whitcomb BW
    Fertil Steril; 2012 May; 97(5):1108-14.e1. PubMed ID: 22365075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful pregnancy and live birth from a hypogonadotropic hypogonadism woman with low serum estradiol concentrations despite numerous oocyte maturations: a case report.
    Matsumoto K; Imakawa K; Hayashi C
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):312. PubMed ID: 28931393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa.
    Olivennes F; Trew G; Borini A; Broekmans F; Arriagada P; Warne DW; Howles CM
    Reprod Biomed Online; 2015 Mar; 30(3):248-57. PubMed ID: 25596910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of controlled ovarian stimulation on thyroid stimulating hormone in infertile women.
    Du YJ; Xin X; Cui N; Jiang L; Yang AM; Hao GM; Gao BL
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():207-212. PubMed ID: 30731333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle.
    Pacchiarotti A; Aragona C; Gaglione R; Selman H
    J Assist Reprod Genet; 2007 Sep; 24(9):400-5. PubMed ID: 17653846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of neither recombinant nor urinary luteinizing hormone was associated with an improvement in the outcome of autologous in vitro fertilization/intracytoplasmatic sperm injection cycles under regular clinical settings: a multicenter observational analysis.
    Schwarze JE; Crosby JA; Zegers-Hochschild F
    Fertil Steril; 2016 Dec; 106(7):1714-1717.e1. PubMed ID: 27678033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.